Madeleine L. Stimpson
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Systemic immunosuppression depletes peripheral blood regulatory B cells in patients with immune thrombocytopenia.
Journal: British journal of haematology
Published: December 19, 2022
CD4+ T cells from patients with glucocorticoid-refractory immune thrombocytopenia have altered cytokine expression.
Journal: British journal of haematology
Published: August 19, 2021
Glucocorticoid treatment in patients with newly diagnosed immune thrombocytopenia switches CD14++ CD16+ intermediate monocytes from a pro-inflammatory to an anti-inflammatory phenotype.
Journal: British journal of haematology
Published: July 14, 2020
IL-10 and IL-17 expression by CD4+ T cells is altered in corticosteroid refractory immune thrombocytopenia (ITP).
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 06, 2020
The DNA Methylation Inhibitor Zebularine Controls CD4+ T Cell Mediated Intraocular Inflammation.
Journal: Frontiers in immunology
Published: May 09, 2019
The Bromodomain and Extra-Terminal Protein Inhibitor OTX015 Suppresses T Helper Cell Proliferation and Differentiation.
Journal: Current molecular medicine
Published: August 22, 2018
Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood-Retinal Barrier Integrity In Vitro.
Journal: Translational vision science & technology
Published: April 17, 2018
Re-programming immunosurveillance in persistent non-infectious ocular inflammation.
Journal: Progress in retinal and eye research
Published: September 12, 2017
Development and validation of a novel bioassay to determine glucocorticoid sensitivity.
Journal: Biomarker research
Published: August 02, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026